James Olzmann

Professor of Molecular Therapeutics and Metabolic Biology at UC Berkeley; Departments of Molecular & Cell Biology and Nutritional Sciences & Toxicology

[James Olzmann @OlzmannLab]

1/ Thrilled to share our new paper in @Nature: “CLCC1 promotes hepatic neutral lipid flux and nuclear pore complex assembly.” From our lab together with @apsarruda, led by co–first authors @alymathiowetz and @EmilyMeymand. 🥳
https://t.co/LHO31rNaxi

[James Olzmann @OlzmannLab]

Exciting new work from @RobertoZoncu, led by all star first authors @clairegoul and @aakritijain24 reveals the mechanism mediating the sensing of lysosomal damage and recruitment of ESCRT for membrane repair. Beautiful work!🤩
https://t.co/fpazvFMciI

[Roberto Zoncu @RobertoZoncu]

Excited to share our new paper: 'LASER couples damage sensing to ESCRT assembly for lysosome repair.' Congrats to dream team @clairegoul and @aakritijain24 for uncovering a new lysosome repair pathway and its connection to neurodegeneration. https://t.co/ZdGtlU0wke

[James Olzmann @OlzmannLab]

Interested in lipids and lipid droplets? This is the meeting to attend this summer! See you there! 🤩

[Sarah Cohen @cohenlaboratory]

Great news! Early registration for the FASEB #LipidSRC has been extended until June 14! It is not too late to submit an abstract and present at the premier North American #LipidDroplet meeting https://t.co/UMCuExFqP6

[Sarah Cohen @cohenlaboratory]

Great news! Early registration for the FASEB #LipidSRC has been extended until June 14! It is not too late to submit an abstract and present at the premier North American #LipidDroplet meeting https://t.co/UMCuExFqP6

[James Olzmann @OlzmannLab]

@UCBerkeley campus. 🤩

[UC Berkeley MCB @berkeleyMCB]

@Eric_Betzig @ABCUCBerkeley One microscope, every scale. MOSAIC images life from single molecules to whole organisms: dividing cells, remodeling organelles, regenerating zebrafish, Alzheimer's tissue at the nanoscale, live mouse neural dynamics. Credit: Fu, Liu, Milkie, Ruan et al., Nature Methods (2026).

[James Olzmann @OlzmannLab]

@UCBerkeley campus. 🙂

[James Olzmann @OlzmannLab]

#NorCal ☺️

[James Olzmann @OlzmannLab]

Who is excited for Bob Farese's seminar @UCBerkeley ?! ME!!! 😀

[James Olzmann @OlzmannLab]

Happy to have contributed to this preprint with Fangzhu Zhao and @realJimWells! LRP8-targeted bispecific antibody degraders degrade the selenium uptake receptor LRP8, reduce GPX4 / selenoproteins, and sensitize cancer cells to ferroptosis.
https://t.co/Ue9HCnnyrI

[James Olzmann @OlzmannLab]

Proud to hood Sydney Tomlinson as she earned her PhD in Metabolic Biology at UC Berkeley. Sydney’s dissertation uncovered mechanisms for induced degradation of ER membrane proteins and advances our understanding of ER quality control.

[James Olzmann @OlzmannLab]

@bstockwell Congrats!!! 🎉

[James Olzmann @OlzmannLab]

Some friendships just keep getting better with time. Really thankful for these guys, the conversations, the laughter, and the chance to slow down and enjoy an evening together. BFFs!☺️ @RobertoZoncu @RapeLab @DanNomura

[James Olzmann @OlzmannLab]

@KamatLab_IISER @BsbeIitb @iitbombay @pnas @PNASNews @the_dope_drug @IISERPune Interesting! Looking forward to reading. :)

[Siddhesh Kamat @KamatLab_IISER]

Another collaborative paper with Roop Mallik’s lab @BsbeIitb @iitbombay is now online @pnas @PNASNews. Wonderful lipidomics work by @the_dope_drug from our lab @IISERPune.

https://t.co/KK6km31Mq0

[James Olzmann @OlzmannLab]

Thrilled to welcome Michael Ward to the Molecular Therapeutics Division at UC Berkeley! 🎉 An incredible addition to our community and a big win for neuroscience and therapeutics at Berkeley. Woohoo!!

[UC Berkeley MCB @berkeleyMCB]

MCB is pleased to welcome ​​​​​​​Michael Ward, Professor of Molecular Therapeutics, on July 1st! Read more about Dr. Ward's research and appointment to UC Berkeley @UCBLettersSci:
https://t.co/tjFeUOGFaq

[UC Berkeley MCB @berkeleyMCB]

MCB is pleased to welcome ​​​​​​​Michael Ward, Professor of Molecular Therapeutics, on July 1st! Read more about Dr. Ward's research and appointment to UC Berkeley @UCBLettersSci:
https://t.co/tjFeUOGFaq

[Jingkun Zeng 曾京昆 @JingkunZeng]

Thrilled to share our new preprint from the Doudna Lab!

“Undruggable” cancer mutations remain very hard to target with current modalities. What if we could instead sense mutant transcripts and convert that recognition into selective cell killing?

https://t.co/AOOFJcM0A1

[James Olzmann @OlzmannLab]

Great to see this Spotlight article in Trends in Cell Biology highlighting our recent identification of a lipid droplet quality control pathway in which FSP1 protects PUFA-rich neutral lipids from peroxidation, thereby suppressing ferroptosis.
https://t.co/oumG9roaOh

[James Olzmann @OlzmannLab]

@Schliekerlab @Yale Exciting! Congrats, Christian! 👏